Clinical Trial Update: The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of sertindole and risperidone on endophenotypic markers in schizophrenia; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• Sertindole (sertindole)

Snippet

Sponsor: Birte Glenthoj | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED